Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH
Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH
Can-Fite BioPharma宣佈加拿大批准其有關用於減少NASH患者肝脂肪的Se的專利申請
Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH
Can-Fite BioPharma宣佈加拿大批准其有關用於減少NASH患者肝脂肪的Se的專利申請
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。